YHL002C-A Antibody

What is YHL002C-A and why is it relevant to yeast biology research?

YHL002C-A is a gene in Saccharomyces cerevisiae (strain 204508/S288c) that encodes a putative uncharacterized membrane protein. The protein's function remains largely unknown, making it an interesting target for fundamental yeast biology research . Antibodies against this protein are particularly valuable for studying membrane protein organization, expression patterns, and potential roles in cellular processes. Research using YHL002C-A antibodies contributes to our understanding of yeast membrane biology, which has broader implications for eukaryotic cellular processes due to the model organism status of S. cerevisiae.

What detection methods work best with YHL002C-A antibody?

The rabbit polyclonal YHL002C-A antibody has been validated for use in ELISA (Enzyme-Linked Immunosorbent Assay) and Western Blot applications . For Western Blot analysis, researchers should optimize protein extraction methods specifically for membrane proteins, as YHL002C-A is a putative membrane protein. This typically involves more rigorous cell lysis procedures and detergent-based extraction buffers to solubilize membrane-bound proteins effectively. For ELISA applications, indirect ELISA formats tend to yield better results when working with yeast membrane proteins, allowing for detection of native protein conformation.

How specific is the YHL002C-A antibody for detecting its target protein?

• Testing the antibody in knockout/knockdown strains lacking YHL002C-A

• Performing peptide competition assays

• Comparing detection patterns with alternative antibodies or tagged protein systems

• Verifying molecular weight correspondence with predicted protein size

Cross-reactivity assessments with related yeast membrane proteins are also recommended before proceeding with extensive experimentation.

What are the optimal fixation and permeabilization conditions for immunofluorescence studies with YHL002C-A antibody?

For immunofluorescence studies targeting membrane proteins like YHL002C-A in yeast cells, a methodological approach involves:

• Fixation: A combination of 3.7% formaldehyde (15 minutes) followed by methanol/acetone mixture (1:1 ratio, -20°C, 5 minutes) typically preserves both protein epitopes and membrane structures.

• Permeabilization: Gentle permeabilization with 0.1% Triton X-100 for 5-10 minutes works well for accessing membrane-associated epitopes without excessive disruption.

• Blocking: Using 3% BSA with 0.1% Tween-20 in PBS for 30-60 minutes helps reduce background signal.

• Primary antibody incubation: Dilutions between 1:100-1:500 of YHL002C-A antibody, incubated overnight at 4°C, typically yield optimal staining with minimal background.

• Controls: Always include a secondary-antibody-only control and, if possible, YHL002C-A deletion strains as negative controls.

This protocol may require optimization based on specific experimental conditions and the particular batch of antibody being used.

How can YHL002C-A antibody be effectively used for co-immunoprecipitation of yeast membrane protein complexes?

Co-immunoprecipitation (Co-IP) of membrane protein complexes containing YHL002C-A requires specific considerations:

• Cell lysis buffer optimization:

  • Use buffer containing 1% NP-40 or 1% digitonin

  • Include 150mM NaCl, 50mM Tris-HCl (pH 7.5), and 1mM EDTA

  • Add protease inhibitor cocktail specifically formulated for yeast

• Cross-linking step:

  • Consider mild cross-linking with 1% formaldehyde for 10 minutes prior to lysis

  • This helps preserve transient protein-protein interactions in membrane complexes

• Antibody coupling:

  • Pre-couple YHL002C-A antibody to Protein A/G beads (5μg antibody per 50μl bead slurry)

  • Incubate for 4 hours at 4°C with rotation

• Sample incubation:

  • Incubate cleared lysate with antibody-coupled beads overnight at 4°C

  • Use gentle rotation to avoid bead damage

• Washing conditions:

  • Perform 5 sequential washes with decreasing salt concentrations

  • Final wash should be in buffer without detergent

• Elution and analysis:

  • Elute with gentle buffer containing 0.1% SDS

  • Analyze associated proteins via mass spectrometry or Western blotting

This methodology preserves membrane protein complexes while minimizing non-specific binding during the immunoprecipitation procedure.

What are the considerations for developing quantitative assays using YHL002C-A antibody?

Developing robust quantitative assays with YHL002C-A antibody requires careful attention to several methodological factors:

• Standard curve establishment:

  • Generate recombinant YHL002C-A protein or synthetic peptide standards

  • Create a 7-point standard curve with 2-fold dilutions

  • Ensure the curve covers the expected physiological concentration range

• Assay format selection:

  • Sandwich ELISA typically provides higher sensitivity and specificity

  • Requires a capture antibody recognizing a different epitope than the detection antibody

  • For YHL002C-A, consider biotinylating the antibody for detection systems

• Sample preparation optimization:

  • Membrane protein extraction requires specialized buffers with appropriate detergents

  • Standardized protocol with internal controls is essential for reproducibility

  • Consider using RIPA buffer with 0.5% sodium deoxycholate for consistent extraction

• Validation metrics:

  • Determine lower limit of detection (LLOD) and quantification (LLOQ)

  • Assess intra-assay and inter-assay coefficient of variation (target <15%)

  • Verify linearity of dilution and recovery of spiked standards

• Data normalization strategy:

  • Normalize to total protein content

  • Consider housekeeping membrane proteins as internal references

  • Account for yeast growth phase effects on expression levels

This comprehensive approach ensures development of reliable quantitative assays for YHL002C-A detection in research applications.

How should researchers interpret multiple bands observed in Western blots using YHL002C-A antibody?

When multiple bands appear in Western blots using YHL002C-A antibody, a systematic analytical approach is necessary:

• Expected band pattern:

  • Primary band at the predicted molecular weight of YHL002C-A (~18-20 kDa, depending on post-translational modifications)

  • Possible dimer/oligomer bands at higher molecular weights if the protein forms complexes

• Post-translational modification analysis:

  • Higher molecular weight bands may represent glycosylated or otherwise modified forms

  • Treat samples with deglycosylation enzymes (PNGase F, Endo H) to confirm glycosylation

  • Phosphatase treatment can identify phosphorylated forms

• Degradation product assessment:

  • Lower molecular weight bands often indicate protein degradation

  • Optimize sample preparation with additional protease inhibitors

  • Compare fresh samples with stored samples to evaluate stability

• Cross-reactivity investigation:

  • Perform peptide competition assays to determine which bands are specific

  • Compare band patterns in wild-type vs. YHL002C-A knockout strains

  • Consider pre-absorbing the antibody with yeast lysate lacking YHL002C-A

• Sample preparation refinement:

  • Modify membrane protein extraction protocols to reduce artificial aggregation

  • Adjust detergent concentrations in sample buffer

  • Optimize heating conditions (temperature and duration)

This analytical framework helps distinguish specific signals from artifacts and enables proper data interpretation.

What are the common causes for weak or absent signal when using YHL002C-A antibody?

Troubleshooting weak or absent signals involves addressing several potential methodological issues:

This structured approach enables researchers to systematically identify and address factors contributing to weak signal when working with YHL002C-A antibody.

How can researchers distinguish between specific and non-specific binding when using YHL002C-A antibody in immunohistochemistry?

Differentiating specific from non-specific binding requires implementing comprehensive control strategies:

• Essential negative controls:

  • Secondary antibody-only control (omit primary antibody)

  • Isotype control (irrelevant primary antibody of same isotype)

  • Genetic negative control (YHL002C-A deletion strain)

  • Peptide competition (pre-incubate antibody with excess target peptide)

• Signal pattern evaluation:

  • Specific staining should correspond to expected subcellular localization (membrane)

  • Non-specific signals often appear diffuse or in unexpected compartments

  • Compare with published localization data or fluorescent protein fusion localization

• Titration analysis:

  • Perform antibody dilution series (1:50 to 1:1000)

  • Specific signals maintain pattern but decrease in intensity

  • Non-specific signals often diminish disproportionately at higher dilutions

• Protocol optimization:

  • Adjust fixation parameters to preserve epitopes while maintaining structure

  • Optimize permeabilization conditions for membrane proteins

  • Modify blocking reagents (test 5% BSA, 5% normal serum, commercial blockers)

• Cross-validation:

  • Confirm localization with independent methods (e.g., tagged protein expression)

  • Compare results across different microscopy techniques (widefield, confocal)

This methodological approach enables researchers to confidently distinguish specific YHL002C-A signals from experimental artifacts.

How can computational antibody design methods like IsAb2.0 be applied to improve YHL002C-A antibody specificity and affinity?

Computational antibody design represents a powerful approach for enhancing YHL002C-A antibody performance:

• Structural modeling approach:

  • Generate 3D models of YHL002C-A protein using AlphaFold-Multimer

  • Predict epitope accessibility on membrane-embedded regions

  • Design antibodies targeting unique, accessible epitopes

• Affinity optimization workflow:

  • Sequence existing YHL002C-A antibody variable regions

  • Apply FlexddG method for in silico affinity maturation

  • Introduce point mutations predicted to enhance binding energy

  • Screen mutations using alanine scanning to identify hotspots

• Cross-reactivity minimization:

  • Perform computational analysis of related yeast membrane proteins

  • Identify unique regions in YHL002C-A sequence

  • Design antibodies targeting these regions to minimize off-target binding

• Validation methodology:

  • Express recombinant antibody variants with predicted improvements

  • Test binding affinity using surface plasmon resonance

  • Evaluate specificity through immunoprecipitation followed by mass spectrometry

This integrated computational-experimental approach leverages advanced AI methods to systematically improve antibody performance for challenging targets like membrane proteins .

What techniques can be used to study the function of YHL002C-A protein using its specific antibody?

Multiple advanced techniques enable functional characterization using YHL002C-A antibody:

• Proximity labeling coupled with immunoprecipitation:

  • Express YHL002C-A fused to BioID or APEX2 proximity labeling enzymes

  • Use YHL002C-A antibody for immunoprecipitation after labeling

  • Identify proximal proteins by mass spectrometry

  • Map potential interaction partners and functional networks

• Live-cell dynamics with antibody fragments:

  • Generate Fab fragments from YHL002C-A antibody

  • Fluorescently label fragments for live imaging

  • Track protein movement in response to environmental stimuli

  • Quantify diffusion coefficients and confined regions

• Functional blocking experiments:

  • Apply antibody to permeabilized cells or membrane preparations

  • Measure effects on transporters, signaling, or enzymatic activities

  • Correlate function inhibition with putative roles

• Conditional degradation systems:

  • Use YHL002C-A antibody conjugated to selective autophagy adaptors

  • Induce targeted degradation of the protein

  • Monitor phenotypic consequences to infer function

  • Compare with genetic knockout approaches

• Structural biology applications:

  • Use antibody to stabilize protein for cryo-EM studies

  • Generate Fab fragments to facilitate crystallization

  • Determine 3D structure of the membrane protein

  • Correlate structure with putative functions

These methodologies extend beyond simple detection to actively probe protein function, enabling comprehensive characterization of this uncharacterized membrane protein.

How can YHL002C-A antibody be integrated into systems biology approaches to understand yeast membrane proteome networks?

Integrating YHL002C-A antibody into systems biology workflows enables network-level insights:

• Immunoprecipitation-mass spectrometry workflow:

  • Perform native immunoprecipitation with YHL002C-A antibody

  • Identify co-precipitated proteins via LC-MS/MS

  • Build protein interaction networks

  • Validate key interactions with reciprocal co-IP

• Multi-antibody membrane proteome profiling:

  • Create antibody panels targeting multiple yeast membrane proteins

  • Perform parallel immunoprecipitations followed by proteomics

  • Construct comprehensive interaction maps

  • Identify protein communities and functional modules

• Spatiotemporal dynamics analysis:

  • Use YHL002C-A antibody in immunofluorescence time course experiments

  • Track localization changes during cell cycle, stress responses

  • Correlate with other membrane protein markers

  • Develop dynamic network models incorporating temporal information

• Quantitative proteomics integration:

  • Measure YHL002C-A abundance across conditions using antibody-based assays

  • Correlate with global proteome changes from mass spectrometry

  • Identify coordinated expression patterns

  • Infer regulatory relationships and pathways

• Bioinformatic data integration framework:

  • Combine antibody-derived interaction data with genomic screens

  • Integrate with published yeast interactome databases

  • Apply machine learning algorithms to predict functional associations

  • Generate testable hypotheses about YHL002C-A function

This systems-level approach positions YHL002C-A antibody as a tool for network biology, enabling researchers to place this uncharacterized protein within broader cellular contexts.

What emerging technologies might enhance YHL002C-A antibody applications in future research?

Several cutting-edge technologies promise to extend the utility of YHL002C-A antibody:

• Single-cell proteomics applications:

  • Adaptation of YHL002C-A antibody for CyTOF mass cytometry

  • Development of multiplex immunofluorescence panels

  • Integration with single-cell RNA-seq for multi-omics profiling

  • Correlation of protein expression with transcriptional programs

• Advanced imaging modalities:

  • Super-resolution microscopy optimized for membrane proteins

  • Expansion microscopy protocols for yeast cells

  • Live-cell single-molecule tracking with antibody fragments

  • Correlative light and electron microscopy applications

• Nanobody and aptamer alternatives:

  • Development of YHL002C-A-specific nanobodies from camelid immunization

  • Selection of RNA/DNA aptamers with specificity for YHL002C-A

  • Creation of synthetic binding proteins through directed evolution

  • Comparison of performance with conventional antibodies

• AI-integrated antibody discovery platforms:

  • Application of deep learning for epitope prediction

  • Computational design of YHL002C-A antibodies with improved properties

  • Machine learning models to optimize purification and conjugation protocols

  • Automated image analysis for antibody validation

These emerging approaches represent the frontier of research tools that will complement and potentially enhance traditional antibody-based methods for studying YHL002C-A and similar challenging proteins.

What are the best practices for validating novel findings obtained using YHL002C-A antibody?

Rigorous validation of research findings requires a multi-faceted approach:

• Independent methodology confirmation:

  • Verify antibody-based findings with orthogonal techniques

  • Confirm protein interactions with reciprocal co-immunoprecipitation

  • Validate localization with fluorescent protein tagging

  • Corroborate expression patterns with RNA analysis

• Genetic validation framework:

  • Generate YHL002C-A knockout strains as negative controls

  • Create point mutants to test functional hypotheses

  • Perform rescue experiments with wild-type protein

  • Use CRISPR-based approaches for endogenous tagging

• Quantitative reproducibility assessment:

  • Establish statistical power through biological replicates

  • Perform blinded analysis where applicable

  • Apply appropriate statistical tests with multiple testing correction

  • Report effect sizes alongside significance values

• Cross-laboratory validation:

  • Share protocols and reagents with collaborating labs

  • Establish reproducibility across different experimental setups

  • Address discrepancies through controlled variable testing

  • Document detailed methodological parameters